Skip to main content
. 2021 Jul 6;28(3):164–172. doi: 10.1016/j.pulmoe.2021.06.009

Table 4.

Results of the probabilistic sensitivity analysis (Monte Carlo Simulation).

Probabilistic Sensitivity Analysis Comparators Mean Cost Per Patient (€) Standard Deviation (± SD) Incremental Cost (€) *
COVID-19 patients prior to hospitalisation Sofia® SARS Antigen FIA −24.76 16.62 0
Conventional approach 185.15 30.58 209.91

Incremental cost denotes the increase in total costs resulting from using the conventional approach alone versus POCT.